Efficacy and safety of ALK inhibitors in ALK-rearranged non-small cell lung cancer: A systematic review and meta-analysis
Daniel Breadner, Phillip Blanchette, Sumugan Shanmuganathan, Gabriel Boldt, Jacques Raphael
Topics & Concepts
MedicineInternal medicineMeta-analysisHazard ratioOncologyAnaplastic lymphoma kinaseCochrane LibraryLung cancerALK inhibitorRandomized controlled trialSubgroup analysisConfidence intervalMalignant pleural effusionLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentLung Cancer Research Studies